Journey Medical Corp (DERM) Gross margin 2020–2025
Journey Medical Corp (DERM) gross margin by fiscal year — reported gross profit divided by reported revenue.
65.8%FY2025 · since FY2020: 67.2% → 65.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 65.8% | +3.7 pp |
| FY2024 | 62.1% | +0.5 pp |
| FY2023 | 61.6% | +5.0 pp |
| FY2022 | 56.7% | +7.5 pp |
| FY2021 | 49.2% | -18.0 pp |
| FY2020 | 67.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice